Enovix Co. (NASDAQ:ENVX) Receives $28.00 Average Target Price from Analysts

Shares of Enovix Co. (NASDAQ:ENVXGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $28.00.

A number of equities analysts have issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 target price on shares of Enovix in a report on Thursday, January 18th. William Blair initiated coverage on Enovix in a report on Monday, December 18th. They set an “outperform” rating on the stock. Finally, B. Riley dropped their price target on Enovix from $25.00 to $18.00 and set a “buy” rating on the stock in a research report on Wednesday, November 8th.

View Our Latest Stock Report on Enovix

Enovix Stock Performance

Enovix stock opened at $12.05 on Tuesday. The company has a current ratio of 8.52, a quick ratio of 8.51 and a debt-to-equity ratio of 0.66. Enovix has a 12-month low of $7.92 and a 12-month high of $23.90. The business’s 50-day simple moving average is $11.53 and its 200 day simple moving average is $12.30.

Institutional Investors Weigh In On Enovix

Several institutional investors have recently bought and sold shares of ENVX. JPMorgan Chase & Co. lifted its stake in Enovix by 5.2% in the 1st quarter. JPMorgan Chase & Co. now owns 106,242 shares of the company’s stock valued at $1,516,000 after acquiring an additional 5,258 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its stake in Enovix by 61.9% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 23,800 shares of the company’s stock valued at $340,000 after acquiring an additional 9,100 shares in the last quarter. HighTower Advisors LLC lifted its stake in Enovix by 18.8% in the 1st quarter. HighTower Advisors LLC now owns 33,723 shares of the company’s stock valued at $483,000 after acquiring an additional 5,335 shares in the last quarter. Citigroup Inc. lifted its stake in Enovix by 129.2% in the 1st quarter. Citigroup Inc. now owns 20,144 shares of the company’s stock valued at $287,000 after acquiring an additional 11,355 shares in the last quarter. Finally, BlackRock Inc. lifted its stake in Enovix by 1.2% in the 1st quarter. BlackRock Inc. now owns 1,498,054 shares of the company’s stock valued at $21,376,000 after acquiring an additional 18,009 shares in the last quarter. Institutional investors own 49.68% of the company’s stock.

About Enovix

(Get Free Report

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.